After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NEO belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Neogenomics Inc is $1.51B. A total of 2.22 million shares were traded on the day, compared to an average of 3.13M shares.
In the most recent transaction, Olivo Alicia C sold 20,916 shares of NEO for 12.00 per share on Nov 25 ’25. After the transaction, the EVP, GC & Business Development now owns 31,083 company shares. In a previous transaction on Nov 25 ’25, ALICIA OLIVO bought 11,939 shares at 11.61 per share.
Among the insiders who bought shares, ALICIA OLIVO acquired of 4,918 shares on Oct 16 ’25 at a per-share price of $9.97. In another insider transaction, Sherman Jeffrey Scott bought 20,000 shares at $5.62 per share on Aug 06 ’25. Company shares held by the Chief Financial Officer now total 188,332.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NEO has a high of $19.11 and a low of $4.72.
As of this writing, NEO has an earnings estimate of $0.04 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.06 per share and a lower estimate of $0.01. The company reported an EPS of $0.04 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NEO’s latest balance sheet shows that the firm has $515.39M in Cash & Short Term Investments as of fiscal 2021. There were $612.79M in debt and $87.23M in liabilities at the time. Its Book Value Per Share was $6.50, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NEO is Buy with a score of 3.79.
